In line with this, high-resolution cell surface proteomic evaluation identified PrPC as a potential biomarker for colorectal adenoma-to-carcinoma progression, which could potentially discriminate normal colon and low-risk adenomas from high-risk adenoma and early-stage colorectal cancer patients [53]. The gene discussed is PRNP; the disease is adenoma.